Note | Although Endosialin was originally described as tumor endothelial marker (Rettig et al., 1992; Seaman et al., 2007; St Croix et al., 2000), it turned out that Endosialin is a marker for activated mesenchymal cells, including myofibroblasts, pericytes and smooth muscle cells (SMC) (MacFadyen et al., 2005; Christian et al., 2008). |
| |
|  |
| |
| Structure of Endosialin and its homologues Thrombomodulin and C1qRp. A: The extracellular domain of Endosialin consists of a signal sequence (orange triangle), a C-lectin like domain (dark green octagon), a Sushi/CCP/scr domain (grey circle), 3 EGF-like domains (red circles), and a negatively charged, O-glycosylated mucin-like domain (light green rectangle). The single transmembrane domain (blue cylinder) is followed by a short cytoplasmic tail (yellow cylinder). B: The globular domains of Endosialin are homologue to thrombomodulin, containing 6 EGF repeats and the complement receptor C1qRp, demonstrating 5 EGF repeats. |
| |
Description | Endosialin is a 757 amino acid (aa) type I C-type lectin-like transmembrane protein (Christian et al., 2001). The core protein has a molecular weight of 95 kDa (Rettig et al., 1992; Christian et al., 2001). The distinct extracellular domain (aa 1-685) consists of a signal leader peptide (aa 1-20) and 5 globular domains followed by a mucin-like region (Figure A) (Christian et al., 2001). The single hydrophobic transmembrane domain spans the aa 686-706, followed by a short intracellular domain of 50 aa (aa 707-757). The 5 globular domains are well defined as C-type lectin-like domain (aa 20-157), a Sushi/CCP/scr like domain (aa 176-230) and 3 EGF repeats (aa 235-271, aa 274-311, aa 316-350). The EGF repeats 2 and 3 are predicted to have a Ca2+ binding function. In contrast, in the C-terminal part (aa 360-757) specific binding sites or catalytic domains were not identified (Christian et al., 2001; Carson-Walter et al., 2001). The glycosylation and sialic acid modification of more than 30 possible O-glycosylation sites, but only N-glycosylation Asn-Xaa-(Ser/Thr) consensus sequence on Asn-628 results in a shift of the molecular weight from 95 kDa to 165 kDa (Rettig et al., 1992; Christian et al., 2001). Additionally, a 120 kDa asialo form of Endosialin was identified (Rettig et al., 1992; Christian et al., 2001). A ~150 kDa form of Endosialin was detectable in the LA1-5s neuroblastoma cell supernatant (Rettig et al., 1992; Christian et al., 2001). |
Expression | Endosialin is expressed in the majority of human carcinomas, sarcomas and neuroectodermal tumors (Rettig et al., 1992; St Croix et al., 2000; Brady et al., 2004; Huber et al., 2006; Madden et al., 2004; Davies et al., 2004; Rmali et al., 2005; Christian et al., 2008) as well as during physiological processes, such as corpus luteum formation and wound healing (Carson-Walter et al., 2001; St Croix et al., 2000). In contrast, Endosialin is not or weakly expressed in the mesenchymal compartment of corresponding normal human tissues (MacFadyen et al., 2007; MacFadyen et al., 2005; Carson-Walter et al., 2001). Endosialin-positive cells in the tumors were identified as myofibroblasts, tumor vessel-associated pericytes and smooth muscle cells (MacFadyen et al., 2005; Huber et al., 2006; Christian et al., 2008; MacFadyen et al., 2007; Bagley et al., 2008a; Virgintino et al., 2007; Simonavicius et al., 2008), although Endosialin was described as tumor endothelial marker (Rettig et al., 1992; St Croix et al., 2000). In addition, recent publications identified Endosialin expressing CD45+ VE-cadherin+ CD146+ CD34+ CD31+ TEM1+ Tem7+ vascular leukocytes (VLC) (Conejo-Garcia et al., 2005), as well as Endosialin-positive VEGFR 2+ CD31+ CD45- VE-cadherin+ endothelial precursor cells (EPC) (Bagley et al., 2008b). During neovascularization of the human fetal telencephalon, Endosialin is expressed by vessel-associated pericytes (Virgintino et al., 2007). In vitro, Endosialin is expressed by fibroblasts, pericytes, smooth muscle cells and preadipocytes (Christian et al., 2008). Some neuroblastoma cell lines including LA1-5s, IMR-32 and SMS-SAN express Endosialin (Rettig et al., 1992). The mouse homologue of Endosialin is strongly and heterogeneously expressed in almost all tissues during embryonic development (Opavsky et al., 2001; Rupp et al., 2006; MacFadyen et al., 2007). The expression is decreased in new-born mice and almost undetectable in tissues of adult mice (Carson-Walter et al., 2001; MacFadyen et al., 2007; Lax et al., 2007; Rupp et al., 2006). |
Localisation | Endosialin is localized on the cell surface (Christian et al., 2001; Christian et al., 2008; MacFadyen et al., 2005). Some staining of the Golgi can also be observed, since Endosialin is a Typ-I transmembrane protein (MacFadyen et al., 2005). |
Function | A role of Endosialin in tumor progression and metastasis was demonstrated by experiments with Endosialin knock-out mice. In abdominal xenograft transplantations, tumor volume and the incidence of distant metastases were significantly reduced in knock-out mice compared to wild type mice, resulting in an increased survival rate of Endosialin-deficient mice (Nanda et al., 2006). Nevertheless, the molecular function of Endosialin is far from being understood. Recent publications demonstrated a role of Endosialin in the proliferation and migration of myofibroblasts (Christian et al., 2008). The tube-formation and migration of Endosialin expressing pericytes could be blocked by anti-Endosialin antibodies (Bagley et al., 2008a). Additionally, Endosialin overexpressing CHO cells demonstrated increased adhesion to fibronectin, migration though Matrigel and MMP-9 activity (Tomkowicz et al., 2007). It is not clarified yet, how these functions of Endosialin result in tumor progression and metastasis. However, these findings indicate a role of Endosialin in early angiogenic stages (Bagley et al., 2008b) and vessel maturation, as well as a function of Endosialin in tumor stroma formation and reorganization of the tumor stroma including tumor blood vessels in tissues where areas of stable blood supply are in close proximity to regions of necrosis, hypoxia and excessive growth (Christian et al., 2001). Interestingly, recent findings described the induction of Endosialin expression by hypoxia, mediated by HIF-2a (Ohradanova et al., 2008). Additionally, Endosialin functions as receptor for extracellular matrix components (Tomkowicz et al., 2007) and tumor cell expressed ligands like Mac-2 Binding Protein. The Endosialin-Mac-2 Binding Protein interaction results in a decreased adhesion between tumor cells and the surrounding myofibroblasts (Becker et al., 2008). However, this mechanism is not analyzed in detail. |
Homology | Whereas the C terminal part of human Endosialin (aa 361-757) showed no sequence homology to other proteins (Christian et al., 2001), the globular N-terminal extracellular part (aa 30-360) demonstrated 39% homology to thrombomodulin precursor protein and 33% homology to the complement receptor C1qRp (Figure B) (Christian et al., 2001). Although there is only moderate sequence identity, cysteine residues predicted to form disulfide bridges and a WIGL consensus motive found in endocytosis regulating proteins (Dean et al., 2000; Nepomuceno et al., 1997) localized in the C-type lectin-like domain are conserved in all three proteins. Mouse Endosialin (mEn) shows 77.5% homology to human Endosialin (Opavsky et al., 2001; Carson-Walter et al., 2001). Like its human counterpart, mEn is a 765 aa type I transmembrane protein with a 17 aa signal peptide, a C-type lectin-like domain (aa 22-157), a Sushi domain (aa 164-230) and 3 EGF-like repeats (aa 234-272, aa 274-311 and aa 315-351), followed by a sialomucin-like region, a single membrane spanning domain (22 aa), and a 51 aa long cytoplasmatic tail. mEn is also transcribed from a single copy, intron-less gene, located on mouse chromosome 19, a region homologue to human chromosome region 11q. The 82 kDa core protein has multiple O- glycosylation sites in the extracellular domain but only one predicted N-glycosylation site on position aa 636, resulting in a glycosylated protein of 92 kDa. Whereas the mucine-like domain of mEn (aa 478-610) and human Endosialin are hardly conserved, the transmembrane domains are identical and only 4 aa are substituted in the cytoplasmatic tails (Carson-Walter et al., 2001; Opavsky et al., 2001). Additionally, possible phosphorylation and N-myristoylation sites as well as a PDZ binding sequence (Carson-Walter et al., 2001) were identified in the intracellular domain, indicating an evolutionary conserved function between mouse and human Endosialin. |
Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization. |
Bagley RG, Honma N, Weber W, Boutin P, Rouleau C, Shankara S, Kataoka S, Ishida I, Roberts BL, Teicher BA. |
Microvasc Res. 2008a Nov;76(3):180-8. Epub 2008 Aug 8. |
PMID 18761022 |
|
Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248. |
Bagley RG, Rouleau C, St Martin T, Boutin P, Weber W, Ruzek M, Honma N, Nacht M, Shankara S, Kataoka S, Ishida I, Roberts BL, Teicher BA. |
Mol Cancer Ther. 2008b Aug;7(8):2536-46. |
PMID 18723498 |
|
Tumor stroma marker endosialin (Tem1) is a binding partner of metastasis-related protein Mac-2 BP/90K. |
Becker R, Lenter MC, Vollkommer T, Boos AM, Pfaff D, Augustin HG, Christian S. |
FASEB J. 2008 Aug;22(8):3059-67. Epub 2008 May 19. |
PMID 18490383 |
|
Human endosialin (tumor endothelial marker 1) is abundantly expressed in highly malignant and invasive brain tumors. |
Brady J, Neal J, Sadakar N, Gasque P. |
J Neuropathol Exp Neurol. 2004 Dec;63(12):1274-83. |
PMID 15624764 |
|
Cell surface tumor endothelial markers are conserved in mice and humans. |
Carson-Walter EB, Watkins DN, Nanda A, Vogelstein B, Kinzler KW, St Croix B. |
Cancer Res. 2001 Sep 15;61(18):6649-55. |
PMID 11559528 |
|
Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells. |
Christian S, Winkler R, Helfrich I, Boos AM, Besemfelder E, Schadendorf D, Augustin HG. |
Am J Pathol. 2008 Feb;172(2):486-94. Epub 2008 Jan 10. |
PMID 18187565 |
|
Vascular leukocytes contribute to tumor vascularization. |
Conejo-Garcia JR, Buckanovich RJ, Benencia F, Courreges MC, Rubin SC, Carroll RG, Coukos G. |
Blood. 2005 Jan 15;105(2):679-81. Epub 2004 Sep 9. |
PMID 15358628 |
|
Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer. |
Davies G, Cunnick GH, Mansel RE, Mason MD, Jiang WG. |
Clin Exp Metastasis. 2004;21(1):31-7. |
PMID 15065600 |
|
Molecular and cellular properties of the rat AA4 antigen, a C-type lectin-like receptor with structural homology to thrombomodulin. |
Dean YD, McGreal EP, Akatsu H, Gasque P. |
J Biol Chem. 2000 Nov 3;275(44):34382-92. |
PMID 10934210 |
|
Expression of stromal cell markers in distinct compartments of human skin cancers. |
Huber MA, Kraut N, Schweifer N, Dolznig H, Peter RU, Schubert RD, Scharffetter-Kochanek K, Pehamberger H, Garin-Chesa P. |
J Cutan Pathol. 2006 Feb;33(2):145-55. |
PMID 16420310 |
|
CD248/Endosialin is dynamically expressed on a subset of stromal cells during lymphoid tissue development, splenic remodeling and repair. |
Lax S, Hou TZ, Jenkinson E, Salmon M, MacFadyen JR, Isacke CM, Anderson G, Cunningham AF, Buckley CD. |
FEBS Lett. 2007 Jul 24;581(18):3550-6. Epub 2007 Jul 3. |
PMID 17628549 |
|
Endosialin is expressed on stromal fibroblasts and CNS pericytes in mouse embryos and is downregulated during development. |
MacFadyen J, Savage K, Wienke D, Isacke CM. |
Gene Expr Patterns. 2007 Jan;7(3):363-9. Epub 2006 Jul 27. |
PMID 16965941 |
|
Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium. |
MacFadyen JR, Haworth O, Roberston D, Hardie D, Webster MT, Morris HR, Panico M, Sutton-Smith M, Dell A, van der Geer P, Wienke D, Buckley CD, Isacke CM. |
FEBS Lett. 2005 May 9;579(12):2569-75. Epub 2005 Apr 7. |
PMID 15862292 |
|
Vascular gene expression in nonneoplastic and malignant brain. |
Madden SL, Cook BP, Nacht M, Weber WD, Callahan MR, Jiang Y, Dufault MR, Zhang X, Zhang W, Walter-Yohrling J, Rouleau C, Akmaev VR, Wang CJ, Cao X, St Martin TB, Roberts BL, Teicher BA, Klinger KW, Stan RV, Lucey B, Carson-Walter EB, Laterra J, Walter KA. |
Am J Pathol. 2004 Aug;165(2):601-8. |
PMID 15277233 |
|
Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumors. |
Nanda A, Karim B, Peng Z, Liu G, Qiu W, Gan C, Vogelstein B, St Croix B, Kinzler KW, Huso DL. |
Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3351-6. Epub 2006 Feb 21. |
PMID 16492758 |
|
cDNA cloning and primary structure analysis of C1qR(P), the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro. |
Nepomuceno RR, Henschen-Edman AH, Burgess WH, Tenner AJ. |
Immunity. 1997 Feb;6(2):119-29. |
PMID 9047234 |
|
Hypoxia upregulates expression of human endosialin gene via hypoxia-inducible factor 2. |
Ohradanova A, Gradin K, Barathova M, Zatovicova M, Holotnakova T, Kopacek J, Parkkila S, Poellinger L, Pastorekova S, and Pastorek J. |
Br. J. Cancer 2008; 99: 1348-1356 |
PMID 18813310 |
|
Molecular characterization of the mouse Tem1/endosialin gene regulated by cell density in vitro and expressed in normal tissues in vivo. |
Opavsky R, Haviernik P, Jurkovicova D, Garin MT, Copeland NG, Gilbert DJ, Jenkins NA, Bies J, Garfield S, Pastorekova S, Oue A, Wolff L. |
J Biol Chem. 2001 Oct 19;276(42):38795-807. Epub 2001 Aug 6. |
PMID 11489895 |
|
Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. |
Rettig WJ, Garin-Chesa P, Healey JH, Su SL, Jaffe EA, Old LJ. |
Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10832-6. |
PMID 1438285 |
|
Immunogenetics of human cell surface differentiation. |
Rettig WJ, Old LJ. |
Annu Rev Immunol. 1989;7:481-511. |
PMID 2653374 |
|
Prognostic values of tumor endothelial markers in patients with colorectal cancer. |
Rmali KA, Puntis MC, Jiang WG. |
World J Gastroenterol. 2005 Mar 7;11(9):1283-6. |
PMID 15761964 |
|
Mouse endosialin, a C-type lectin-like cell surface receptor: expression during embryonic development and induction in experimental cancer neoangiogenesis. |
Rupp C, Dolznig H, Puri C, Sommergruber W, Kerjaschki D, Rettig WJ, Garin-Chesa P. |
Cancer Immun. 2006 Jul 31;6:10. |
PMID 16875435 |
|
Genes that distinguish physiological and pathological angiogenesis. |
Seaman S, Stevens J, Yang MY, Logsdon D, Graff-Cherry C, St Croix B. |
Cancer Cell. 2007 Jun;11(6):539-54. |
PMID 17560335 |
|
Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma. |
Simonavicius N, Robertson D, Bax DA, Jones C, Huijbers IJ, Isacke CM. |
Mod Pathol. 2008 Mar;21(3):308-15. Epub 2008 Jan 11. |
PMID 18192970 |
|
Genes expressed in human tumor endothelium. |
St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW. |
Science. 2000 Aug 18;289(5482):1197-202. |
PMID 10947988 |
|
Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration. |
Tomkowicz B, Rybinski K, Foley B, Ebel W, Kline B, Routhier E, Sass P, Nicolaides NC, Grasso L, Zhou Y. |
Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):17965-70. Epub 2007 Nov 6. |
PMID 17986615 |
|
An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis. |
Virgintino D, Girolamo F, Errede M, Capobianco C, Robertson D, Stallcup WB, Perris R, Roncali L. |
Angiogenesis. 2007;10(1):35-45. Epub 2007 Jan 17. |
PMID 17225955 |
|